Soundararajan R, Wang G, Petkova A, Uchegbu IF, Schätzlein AG. Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route. Mol Pharm. 2020;17(7):2599-2611.

2020

Odunze U, O'Brien F, Godfrey L, Schatzlein A, Uchegbu I. Unusual Enthalpy Driven Self Assembly at Room Temperature with Chitosan Amphiphiles. Pharm Nanotechnol. 2019;7(1):57-71.

2019

Pérez-Cantero A, Serrano DR, Navarro-Rodríguez P, Schätzlein AG, Uchegbu IF, Torrado JJ, et al. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC Natural Adjuvant against Aspergillosis. Pharmaceutics. 2019;11(9).

2019

Wang Z, Xiong G, Tsang WC, Schätzlein AG, Uchegbu IF. Nose-to-Brain Delivery. J Pharmacol Exp Ther. 2019;370(3):593-601.

2019

Godfrey L, Iannitelli A, Garrett NL, Moger J, Imbert I, King T, et al. Nanoparticulate peptide delivery exclusively to the brain produces tolerance free, analgesia. Journal of Controlled Release. 2017;E-pub ahead of print.

2017

Soundararajan R, Sasaki K, Godfrey L, Odunze U, Fereira N, Schatzlein A, et al. Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate. International Journal of Pharmaceutics. 2016;514(1):121-132.

2016

Fisusi FA, Siew A, Chooi KW, Okubanjo O, Garrett N, Lalatsa K, et al. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments. Pharmaceutical Research. 2016:1-15.

2016

Serrano DR, Lalatsa A, M Dea-Ayuela A, Bilbao-Ramos PE, Garrett NL, Moger J, et al. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles. Molecular pharmaceutics. 2015;12(2):420-431.

2015

Lalatsa A, Schätzlein AG, Garrett NL, Moger J, Briggs M, Godfrey L, et al. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration. Journal of controlled release : official journal of the Controlled Release Society. 2015;197:87-96.

2015

Lalatsa A, Schätzlein AG, Uchegbu IF. Strategies To Deliver Peptide Drugs to the Brain. Molecular pharmaceutics. 2014;11(4):1081-1093.

2014

Chooi KW, Carlos MI, Soundararajan R, Gaisford S, Arifin N, Schätzlein AG, et al. Physical Characterisation and Long‐Term Stability Studies on Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ)—A New Drug Delivery Polymer. Journal of Pharmaceutical Sciences. 2014.

2014

Uchegbu IF, Jones MC, Corrente F. The Oral and Intranasal Delivery of Propofol Using Chitosan Amphiphile Nanoparticles. Pharmaceutical …. 2014.

2014

Uchegbu IF, Carlos M, McKay C, Hou X, Schätzlein AG. Chitosan amphiphiles provide new drug delivery opportunities. Polymer International. 2014.

2014

Mazza M, Notman R, Anwar J, Rodger A, Hicks M, Parkinson G, et al. Nanofiber-based delivery of therapeutic peptides to the brain. ACS nano. 2013;7(2):1016-1026.

2013

Le HT, Schätzlein AG, Uchegbu IF. Polymer Hydrophobicity Has a Positive Effect on the Oral Absorption of Cyclosporine A from Poly(ethylenimine) Based Nanomedicines. Pharmaceutical Nanotechnology. 2013;1:15-25.

2013

Lalatsa A, Garrett NL, Ferrarelli T, Moger J, Schätzlein AG, Uchegbu IF. Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles. Molecular pharmaceutics. 2012;9(6):1764-1774.

2012

Lalatsa A, Lee V, Malkinson JP, Zloh M, Schätzlein AG, Uchegbu IF. A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine 5-enkephalin, to the Brain. Molecular pharmaceutics. 2012;9(6):1665-1680.

2012

Garrett NL, Lalatsa A, Uchegbu I, Schatzlein A, Moger J. Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy. Journal of Biophotonics. 2012;5(5-6):458-468.

2012

Siew A, Le H, Thiovolet M, Gellert P, Schatzlein A, Uchegbu I. Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. Molecular pharmaceutics. 2012;9(1):14-28.

2012

Garrett NL, Lalatsa A, Begley D, Mihoreanu L., Uchegbu IF, Schätzlein AG, et al. Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy. Journal of Raman Spectroscopy. 2012;43(5):681-688.

2012

Ahmad S, Johnston BF, Mackay SP, Schätzlein AG, Gellert P, Sengupta D, et al. In silico modelling of drug-polymer interactions for pharmaceutical formulations. Journal of The Royal Society Interface. 2010;7 Suppl 4:S423-33.

2010

Qu X, Khutoryanskiy VV, Stewart A, Rahman S, Papahadjopoulos-Sternberg B, Dufes C, et al. Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude. Biomacromolecules. 2006;7(12):3452-3459.

2006

Uchegbu IF, Sadiq L, Arastoo M, Gray AI, Wang W, Waigh RD, et al. Quaternary ammonium palmitoyl glycol chitosan--a new polysoap for drug delivery. International Journal of Pharmaceutics. 2001;224(1-2):185-199.

2001